Search clinical trials for: Bcl-2 Inhibitor GDC-0199
Total 7089 results
-
AbbVieAvailableMultiple Myeloma | Non-Hodgkin's Lymphoma | Amyloidosis | Chronic Lymphocytic Leukemia (CLL) | Acute Myeloid Leukemia (AML) | Acute Lymphoblastic Leukemia (ALL) | Plasma Cell Leukemia
-
Fondazione Italiana Linfomi - ETSTerminatedT-Cell Lymphoma Relapsed | T-Cell Lymphoma RefractoryItaly
-
Kerry RogersActive, not recruitingChronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic LeukemiaUnited States
-
AbbVieGenentech, Inc.CompletedNon-Hodgkin's LymphomaUnited States
-
AbbVieRecruitingChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL)Australia, China, New Zealand, Taiwan
-
AbbVieGenentech, Inc.WithdrawnRelapsed/Refractory Non-Hodgkin's Lymphoma
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Acute Myeloid Leukemia | Acute Myeloid Leukemia With FLT3/ITD Mutation | Refractory Acute LeukemiaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterWithdrawnRecurrent Mantle Cell Lymphoma | Refractory Mantle Cell LymphomaUnited States
-
AbbVieRoche-GenentechCompletedRenal Impairment | Renal DiseaseUnited States
-
AbbVieGenentech, Inc.CompletedChronic Lymphocytic Leukemia | 17p Deletion | Cancer of the Blood and Bone MarrowUnited States, Australia, Canada, France, Germany, Poland, United Kingdom
-
AbbVieAvailableMyelofibrosis | Lymphoblastic Lymphoma | Acute Lymphocytic Leukemia (ALL)United States
-
Kerry RogersJanssen Research & Development, LLCWithdrawnChronic Lymphocytic Leukemia | Loss of Chromosome 17p
-
Ohio State University Comprehensive Cancer CenterActive, not recruitingChronic Lymphocytic Leukemia | Ibrutinib ResistanceUnited States
-
Roswell Park Cancer InstituteAbbVieCompletedCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | PSA Progression | Metastatic Prostate Carcinoma in the Soft Tissue | Castration Levels of Testosterone | Prostate Carcinoma...United States
-
Fred Hutchinson Cancer CenterAstraZenecaRecruitingRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States
-
Steven E. CoutreCompletedRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States
-
M.D. Anderson Cancer CenterAbbVie; Syndax Pharmaceuticals; Break Through CancerNot yet recruiting
-
AbbVieAstellas Pharma Inc; Genentech, Inc.CompletedAcute Myeloid Leukemia (AML)United States
-
AbbVieGenentech, Inc.Active, not recruiting
-
PrECOG, LLC.Genentech, Inc.CompletedFollicular Lymphoma | Non-Hodgkin's Lymphoma Follicular | Non-Hodgkin's Lymphoma, Adult High GradeUnited States
-
Genentech, Inc.Completed
-
AbbVieMerck Sharp & Dohme LLCTerminatedCancer - Acute Myeloid LeukemiaUnited States, Australia, Spain
-
Brian DrukerAbbVie; Oregon Health and Science University; Incyte CorporationActive, not recruitingAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
Hoffmann-La RocheCompletedMultiple MyelomaSpain, Denmark, Netherlands, Sweden, Poland, France, Germany, Czechia, Norway
-
AbbVieTerminatedAcute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS)United States, Australia, Germany, Israel, Italy, Japan, Spain
-
Genentech, Inc.AbbVie (prior sponsor, Abbott)CompletedLymphocytic Leukemia, ChronicUnited States, United Kingdom
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingAcute Myeloid Leukemia | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Chronic Myelomonocytic Leukemia | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic... and other conditionsUnited States
-
AbbVieF. Hoffmann-La Roche Ltd; German CLL Study Group (GCLLSG); Dana-Farber Cancer...RecruitingChronic Lymphocytic Leukemia (CLL)United States, Australia, Austria, Bulgaria, Germany, Italy, Spain, Israel, Brazil, Romania
-
AbbVieCompletedLeukemia | Cancer | T-cell Prolymphocytic Leukemia (T-PLL)United States, Australia, Austria, Finland, France, Germany, Italy, Netherlands, United Kingdom
-
Craig Portell, MDAbbVieCompletedLymphoma, Mantle-Cell | Recurrent Lymphoma, Mantle-CellUnited States
-
AbbVieGenentech, Inc.Active, not recruitingMyelodysplastic Syndrome (MDS)United States, Australia, Austria, Belgium, Brazil, Canada, China, Czechia, France, Germany, Hungary, Israel, Italy, Japan, Korea, Republic of, Netherlands, Poland, Puerto Rico, Russian Federation, Spain, Taiwan, Turkey, United Kingdom
-
AbbVieCelgene; Genentech, Inc.CompletedMyelodysplastic Syndromes (MDS)United States, Australia, Germany
-
AbbVieGenentech, Inc.Active, not recruitingMyelodysplastic Syndromes (MDS)United States, Australia, Canada, France, Germany, Italy, United Kingdom
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Genentech, Inc.RecruitingAcute Myeloid Leukemia | Therapy-Related Acute Myeloid Leukemia | Hematologic and Lymphocytic Disorder | Acute Myeloid Leukemia in Remission | FLT3 Gene Mutation | Minimal Residual Disease PersistenceUnited States
-
The First Affiliated Hospital of Soochow UniversityRecruitingAcute Myeloid Leukemia (AML) in RemissionChina
-
AbbVieActive, not recruitingCancer | Acute Myeloid Leukemia (AML)United States, Australia, Brazil, Canada, China, Czechia, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Spain, Switzerland, Taiwan, United Kingdom
-
M.D. Anderson Cancer CenterRecruitingChronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterRecruitingHematopoietic and Lymphoid Cell Neoplasm | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome | Recurrent Acute Biphenotypic Leukemia | Refractory Acute Biphenotypic LeukemiaUnited States
-
National Cancer Institute (NCI)Active, not recruitingAcute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell Lymphoma | CD20 Positive | Refractory Mantle Cell Lymphoma | Blastoid Variant Mantle Cell Lymphoma | CCND1 Protein Overexpression | CD5 Positive | FCER2 Negative | Pleomorphic Variant Mantle Cell Lymphoma | t(11;14)(q13;q32)United States
-
Swiss Group for Clinical Cancer ResearchCompletedFollicular LymphomaSwitzerland
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingChronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous LeukemiaUnited States
-
The First Affiliated Hospital of Soochow UniversityRecruitingB Acute Lymphoblastic Leukemia | High Risk Acute Lymphoblastic Leukemia | Ph-Negative ALLChina
-
Nantes University HospitalRoche Pharma AG; Janssen, LPActive, not recruitingMantle Cell LymphomaFrance, United Kingdom
-
M.D. Anderson Cancer CenterActive, not recruitingChronic Lymphocytic Leukemia | Recurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States
-
AbbVieActive, not recruiting
-
AbbVieActive, not recruitingChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL)Japan
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterRecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States